All Stories

  1. Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study
  2. 1 LOCK-IT-100: CRMD003, A Novel Taurolidine-Based Catheter Lock Solution Reduces Catheter-Related Bloodstream Infections in Hemodialysis
  3. Access Blood Flow Testing
  4. How Should Symptomatic Central Vein Stenosis be Managed in Hemodialysis Patients?
  5. Thrombocytopenia in ESRD Patients: Epidemiology, Mechanisms and Interventional Nephrology Perspective
  6. Dialysis Therapies: A National Dialogue
  7. Approach to Arteriovenous Access
  8. Approach to a Patient with Non-maturing AV Fistula
  9. Operative Considerations for Peritoneal Dialysis Catheter
  10. In Reply to ‘The Other Side of the Central Vein Stenosis Story’
  11. Central Vein Stenosis
  12. Impact of post‐kidney transplant parathyroidectomy on allograft function
  13. Anemia associated with chronic heart failure: current concepts
  14. Cardiorenal Syndrome and the Role of Ultrafiltration in Heart Failure
  15. Pumping iron: revisiting risks, benefits and strategies in treatment of iron deficiency in end-stage renal disease
  16. Academic Interventional Nephrology: A Model for Training, Research, and Patient Care
  17. Dialysis Access Dysfunction
  18. Bath Salts: A Newly Recognized Cause of Acute Kidney Injury
  19. Catheter Outcomes in the Short‐term Inpatient Setting: A Controlled Quality Improvement Study Comparing Citrate and Heparin Lock
  20. Dialysis Vascular Access Management by Interventional Nephrology Programs at University Medical Centers in the United States
  21. 138 Acute Kidney Injury as the Initial Presentation of Acute Retroviral Syndrome
  22. Iatrogenic Graft to Vein Fistula (GVF) Formation Associated with Synthetic Arteriovenous Grafts
  23. Therapy with Erythropoiesis-Stimulating Agents and Renal and Nonrenal Outcomes
  24. Future Directions in Management of Anemia in Heart Failure
  25. Preface
  26. ASDIN: Patency Rates for Angioplasty in the Treatment of Pacemaker‐Induced Central Venous Stenosis in Hemodialysis Patients: Results of a Multi‐Center Study
  27. Central Vein Stenosis: Current Concepts
  28. Anemia after intensive care unit stay: More questions than answers*
  29. Drug safety profile of darbepoetin alfa for anemia of chronic kidney disease
  30. Progression of Kidney Disease: Diagnosis and Management
  31. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease
  32. Darbepoetin alfa for anemia in chronic kidney disease
  33. 228: An Unusual Cause of Malignant Hypertension
  34. 1
  35. Central Vein Stenosis: A Nephrologist's Perspective
  36. Usual ACE Inhibitor Therapy in CKD Patients Is Associated with Lower Plasma Aldosterone Levels than Usual Angiotensin Receptor Blocker Therapy
  37. Practical Approach to the Diagnosis and Treatment of Anemia Associated With CKD in Elderly
  38. Proposed Pathogenesis of Idiopathic Loin Pain–Hematuria Syndrome
  39. Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression
  40. American Society of Diagnostic and Interventional Nephrology Section Editor: Stephen Ash: Does Catheter Insertion by Nephrologists Improve Peritoneal Dialysis Utilization? A Multicenter Analysis
  41. Textbook of Nephrology for Asian-Pacific Physicians
  42. Chapter-23 Urinary Stones
  43. Chapter-24 Cystic Diseases of Kidney
  44. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys